|Mr. Florian Schönharting||Co-Founder & Chairman||N/A||N/A||1969|
|Dr. Claus Bo Svendsen||CEO & Principal Financial Officer||N/A||N/A||1977|
|Mr. Thomas Carbone||Principal Accounting Officer||N/A||N/A||1957|
Forward Pharma A/S, a biopharmaceutical company, focuses on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.